Viewing Study NCT03340506

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 5:23 PM
Ignite Modification Date: 2026-02-06 @ 10:48 AM
Study NCT ID: NCT03340506
Status: RECRUITING
Last Update Posted: 2025-11-10
First Post: 2017-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Dabrafenib and/or Trametinib Rollover Study
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
None Non Small Cell Lung Cancer View
None Solid Tumor View
None Rare Cancers View
None High Grade Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tafinlar View
None Mekinist View
None Dabrafenib View
None Trametinib View
None Adult View
None Melanoma View
None Melanoma Stage IV View
None Metastatic Melanoma View
None Advanced Melanoma View
None Lung Cancer View
None NSLC View
None Non Small Cell Lung Cancer View
None BRAF V600 Mutation View
None BRAF Gene Mutation View
None Solid tumor View
None Rare cancers View
None High Grade Glioma View